Visionary Holdings Inc. 2025 Annual General Meeting Concludes Successfully: Completes Board Renewal, Anchors New Direction for Compliant Development

Rhea-AI Summary

Visionary Holdings (NASDAQ:GV) held its 2025 Annual General Meeting on Oct 31, 2025, with 97.79% of voting rights represented. Shareholders approved a 16-member 4th Session Board slate (9 elected directors named) to serve through the 2026 AGM, reappointed Assentsure PAC as auditor for the Apr 1, 2025–Mar 31, 2026 year, and approved the 2024–2025 financial and board reports. Reported metrics: core businesses contributed 78% of revenue, new big-health net profit grew 100% YoY, total assets were USD 68,792 thousand, and the asset‑liability ratio was 80%. The first board meeting is scheduled for Nov 3, 2025.

Positive

• New-business net profit +100% YoY
• Total assets USD 68,792 thousand
• Core businesses account for 78% of revenue
• Auditor reappointed (Assentsure PAC) PCAOB‑registered

Negative

• High leverage with an asset‑liability ratio of 80%
• Concentrated revenue: 78% from core businesses (real estate, education, big health)

TORONTO, Oct. 31, 2025 /PRNewswire/ -- Visionary Holdings Inc. (hereinafter referred to as the "Company"; a diversified enterprise registered in Ontario, Canada and listed on the Nasdaq Capital Market under the ticker symbol: GV) successfully held its 2025 Annual General Meeting (AGM) via Zoom video conference from 10:00 a.m. to 12:00 p.m. ET (UTC-4) on the same day. Chaired by Mr. Robert Jay LEES, the voting rights represented by attending shareholders and their proxies accounted for 97.79% of the company's total voting rights, far exceeding the quorum requirements stipulated in the Business Corporations Act (Ontario, 1990), Nasdaq Listing Rules, and the company's Articles of Association. The meeting's convening procedures and agenda items were in compliance with laws and regulations, fully safeguarding shareholders' rights to participation and voting.

During the meeting, shareholders and their proxies conducted in-depth discussions on core agenda items including board renewal, reappointment of auditors, and review of the annual report. Eventually, all proposals were approved with an overwhelming majority, laying a solid institutional foundation for the company's governance enhancement and business layout in the next fiscal year.

I. Renewal of the 4th Session of the Board of Directors: Professional Team to Support Strategic Implementation

As the core agenda of this meeting, the Company strictly adhered to the U.S. SEC's director independence standards and Nasdaq's mandatory rule of "a majority of independent directors (≥50%)". The Nomination Committee, through public solicitation and multiple rounds of interview evaluations, selected 16 qualified candidates (including 9 incumbents and 7 new members) from 18 candidate profiles, covering key fields such as corporate management, financial management, legal compliance, international education, high-end medical aesthetics and big health, and biotechnology.

Based on the statistics from the dual voting mode of "on-site voting + email voting", 9 candidates – Mr. William T. Chai, Mr. Kealey Donald M, Mr. Jun Huang, Mr. Rusheng Wu, Mr. Robert Jay LEES, Ms. Jiena Zhang, Mr. Weixing Wang, Mr. Yi Wang and Mr. Henry Sun – were officially elected as members of the 4th Session of the Board of Directors, having received more than two-thirds of the affirmative votes from the valid voting rights of attending shareholders. Their term will run from the effective date of the resolution of this AGM to the end of the 2026 Annual General Meeting.

With their cross-sector professional backgrounds and rich practical experience, the new board members will provide diverse perspectives for the company's strategic decision-making, further optimize the governance structure, and effectively safeguard the long-term interests of all shareholders.

II. Reappointment of Auditors: Strengthening the Defense Line of Financial Compliance

To meet the stringent audit supervision requirements of the U.S. SEC and Nasdaq for listed companies, the meeting approved the Proposal on the Appointment of Auditors for the 2025-2026 Fiscal Year, agreeing to reappoint Assentsure PAC as the company's auditor for the 2025-2026 fiscal year (April 1, 2025 to March 31, 2026).

Assentsure PAC has completed registration with the U.S. Public Company Accounting Oversight Board (PCAOB) and holds the legal qualification to provide audit services for U.S.-listed companies. During the 2024-2025 fiscal year audit work, its core team, supported by over 6 years of cross-border audit experience, efficiently completed the financial statement audit and internal control evaluation. The audit conclusions truly reflected the company's financial status, and its professional capabilities have been recognized by the company and shareholders. After this reappointment, Assentsure PAC will continue to be responsible for statutory matters such as the company's annual financial statement audit and SEC periodic report audit. The audit service fee will remain consistent with the previous fiscal year (excluding audit travel expenses and fees for additional matters), ensuring that the company's financial information disclosure is "true, accurate, complete, timely and fair".

III. Review of Annual Reports: Clarifying Operating Results and Development Path

The meeting approved the 2024-2025 Fiscal Year Financial Report and 2024-2025 Fiscal Year Board of Directors' Work Report with an overwhelming majority, conducting a comprehensive review of the company's operating performance and strategic progress in the past fiscal year (April 1, 2024 to March 31, 2025):

Financial Performance: The revenue of the company's core businesses (real estate, education, and big health) accounted for 78%. The net profit of the new business (big health projects) achieved a year-on-year growth of 100%, demonstrating remarkable results in business transformation. Total assets remained stable at USD 68,792 thousand, and the asset-liability ratio was controlled at 80%, maintaining a sound financial structure and providing sufficient resilience for future development.

Business and Governance Progress: On the market front, the company established branches in China, added more than 30 new clients, maintained customer satisfaction at over 80%, and continuously enhanced its international brand influence. On the strategic front, it deployed in the fields of artificial intelligence and big health, completed the acquisition of the Changle Shuang Big Health Project and the strategic investment in the new energy vehicle project, expanding its growth tracks. On the governance front, it revised the Articles of Association and Rules of Procedure for the Board of Directors, strengthened internal control and risk management, and further improved its compliant operation capabilities.

The reports clearly stated that in the next fiscal year, the company will focus on three major goals: "improving the quality of core businesses, accelerating the development of emerging businesses, and strengthening compliant governance", increase R&D investment and talent development, and promote high-quality business development.

IV. Confirmation of Statutory Matters: Consolidating the Foundation for Compliant Operations

To ensure the legality and continuity of the company's governance, the meeting reviewed and approved three key statutory matters:

1.Confirmed the legality and validity of the election results for the 4th Session of the Board of Directors, verifying that the qualifications of the new board members comply with the requirements of laws, regulations and the company's Articles of Association;

2.Confirmed the validity of the appointment of Assentsure PAC as the company's auditor for the 2025-2026 fiscal year, and clarified its audit responsibilities and service scope;

3.Approved the 2024-2025 Fiscal Year Form 20-F, ensuring that the annual report submitted by the company to the U.S. SEC complies with information disclosure regulatory requirements.

V. Follow-up Arrangements: First Meeting of the 4th Session of the Board of Directors to Be Held Soon

In accordance with the resolution of this AGM, the first meeting of the 4th Session of the Board of Directors will be held via Zoom video conference at 10:00 a.m. on November 3, 2025 (ET). The core agenda will include: electing the Chairman of the Board, Executive Directors, and Secretary of the Board; determining the members of the four special committees (Audit, Nomination, Remuneration, and Investment); and appointing the senior management team including CEO, Co-CEO, CFO, and Vice Presidents. The relevant meeting resolutions will be disclosed through the "Investor Relations" section on the company's official website (www.visionary.holdings) within 48 hours after the meeting, ensuring that shareholders are promptly informed of the company's governance developments.

The Board of Directors of Visionary Holdings Inc. stated: "The successful convening of this Annual General Meeting has injected new governance momentum into the company. The 4th Session of the Board of Directors will take 'being responsible to shareholders and seeking development for the company' as its core, diligently perform its duties, deepen business innovation on the basis of compliant operations, continuously enhance the company's core competitiveness, and create long-term and stable value returns for all shareholders."

 

View original content:https://www.prnewswire.com/news-releases/visionary-holdings-inc-2025-annual-general-meeting-concludes-successfully-completes-board-renewal-anchors-new-direction-for-compliant-development-302599227.html

SOURCE Visionary Holdings Inc.

FAQ

What were the key outcomes of Visionary Holdings' Oct 31, 2025 AGM for GV shareholders?

Shareholders elected the 4th Session board, reappointed Assentsure PAC as auditor for Apr 1, 2025–Mar 31, 2026, and approved the 2024–2025 financial and board reports.

Which directors were elected to Visionary Holdings' 4th Session board at the 2025 AGM (GV)?

Nine directors named as elected include William T. Chai, Kealey Donald M, Jun Huang, Rusheng Wu, Robert Jay Lees, Jiena Zhang, Weixing Wang, Yi Wang, and Henry Sun.

How did Visionary Holdings report financials for the 2024–2025 year (GV)?

The company reported total assets of USD 68,792 thousand, an asset‑liability ratio of 80%, core businesses at 78% of revenue, and new big‑health net profit up 100% YoY.

When will Visionary Holdings' new board hold its first meeting after the Oct 31, 2025 AGM (GV)?

The first meeting of the 4th Session board is scheduled for Nov 3, 2025 at 10:00 a.m. ET to appoint chair, committees, and senior management.

What auditor will conduct Visionary Holdings' 2025–2026 audit for GV and is it PCAOB‑registered?

Assentsure PAC was reappointed for the 2025–2026 fiscal year and is registered with the U.S. PCAOB to audit U.S.‑listed companies.